用于治疗药物监测的迪戈辛,,,氨酸,氨酸和万科米辛的细胞内稳定性
Heather A Nelson1,2, Chad Condie3, Kelly Doyle1,2
1Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
用于治疗药物监测的迪戈辛,,氨酸,氨酸,氨酸和万科米辛的样本在室温下稳定12小时. 这一发现减少了临床实验室的样本排斥和处理限制.
科学领域:
- 临床化学 临床化学
- 药理学 药理学是指药理学的学科.
- 实验室医学 实验室医学
背景情况:
- 在治疗药物监测 (TDM) 中的样本处理延迟可能导致拒绝.
- 目前的TDM协议要求在2小时内离心.
- 门诊设置往往涉及更长的运输,挑战及时的样本处理.
研究的目的:
- 评估五种关键的TDM药物的稳定性.
- 为了确定延迟离心法对药物度的影响.
- 在室温下存储在细胞上的全血中评估药物的稳定性.
主要方法:
- 分析了五种药物 (迪戈辛,,素,酸,万科米辛).
- 血液样本在室温下存储在细胞上0.5,6和12小时.
- 度与基线 (0.5小时) 相比,使用重复测量ANOVA.
主要成果:
- 所有五种药物的度都保持在基线的±10%.
- 在室温下在细胞内存储长达12小时的稳定性得到证实.
- 芬伊托因的稳定性进一步通过多个时间点的尖端样本进行了验证.
结论:
- 迪戈辛,,氨酸,氨酸,氨酸和万科米辛在12小时内保持稳定.
- 对于这些TDM药物来说,在室温下延长细胞内存储是可行的.
- 这些发现可以缓解TDM样品的临床实验室处理约束.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
相关概念视频
Heart Failure Drugs: Inotropic Agents
Time Course of Drug Effect
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Determination of Michaelis Constant and Maximum Elimination Rate
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
Drug Concentrations: Measurements
Plasma...
